Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease

Metabolites, the biochemical products of the cellular process, can be used to measure alterations in biochemical pathways related to the pathogenesis of Alzheimer's disease (AD). However, the relationships between systemic abnormalities in metabolism and the pathogenesis of AD are poorly understo…